Schedule 13G/A
CARAEUR Schedule 13G/A filing by BlackRock
BlackRock reported beneficial ownership of 3.6M shares, representing 6.5% of CARA THERAPEUTICS INC in this filing.
FiledJan 29, 2024
Ownership dateDec 31, 2023
Reported shares3.6M
Reported ownership6.5%
Ownership details
Voting and dispositive power reported in the filing
These figures describe the reporting filer’s disclosed voting and investment authority. They should be read together with the reported share count and percentage.
Sole voting power
3.6M
Shared voting power
3.6M
Sole dispositive power
3.6M
Shared dispositive power
3.6M
Compared with the prior filing
How the reported position changed
This compares the current filing with the previous tracked Schedule 13 filing from the same reporting CIK for CARAEUR. A change between filings does not by itself establish when shares were bought or sold.
Previous filingJul 7, 2023
Reported share change-147,710
Ownership percentage change-0.4 pts
| Previous filing | This filing | |
|---|---|---|
| Reported shares | 3.7M | 3.6M |
| Reported ownership | 6.9% | 6.5% |
Source
Original filing and accession
Use the SEC filing as the primary source when you need the complete disclosure, footnotes, exhibits, or reporting-person details.
- Reporting filer
- BlackRock
- CIK
- CIK0001364742
- Accession
- 0001086364-24-005153
- Form
- Schedule 13G/A
Read the filing in context